GreenSignal BIO is a micro cap Pharma Company with a MC of approx 300 Cr. It is two horse pony with only 2 products and few in the pipeline so it is highly risk. If you base it 2015 financial it is clear avoid however it 2016 Financial is good but how much is windows dressing. If a take annualised EPS from July quarter i still get a PE of 26 which if a compare with industry it is still low.but if compare to like to like company with TO of 10cr to 100 Cr and NP of 5cr to 10cr it okay nothing much. Also big 2013 to 2014 not sure the reason may be rejection or faulty batch so this kind of issue will occur in future also.
THIS BIGGEST WEAK POINT IS THE SIZE ONLY 8500 APPROX APPLICANT WILL LET 175 SHARES SO BIG LUCK WILL PLAY
Serum ONE OF BIGGEST VACCINE PRODUCER IS A PRIVATELY HELD COMPANY WITH TOPLINE 4000 CR AND BOTTOM LINE 2000CR SO ITS NP MARGIN IS 50% THEY VAULED THIS COMPAMY 82000 CRS WHICH 100 TIME BIG AND NP MARGIN IS 50% GREENSINGAL NP MARGINS 25% on a very high regulated product SO SALES IS 100 TIMES SMALL AND ON NP MARGIN IT HALF EFFICIENTY MEANING ON NUMBER TERMS IT IS 200 TIMES SMALL
SO 82000/200= 410 CR AT 25% MIS THE MC IS 308 CRS SO LIVE SO MANY OTHER ISSUE IT IS PRICE TO PERFECTION COMES TO 307 CR AT RS 80
HOWEVER SINCE NO LISTED PLAYERS T GROUP LISTING ONE CAN APPLY SO SOME UPSIDE ON LISTING ALSO IF TOPLINE IMPROVES AND MARGINS IMPROVE LONG RUN IT WILL BE GOOD STOCK S
SO ONE CAN APPLY IMO IT WILL BE OVER SUBSCRIBED BY AT LEAST 20 TIMES IN RII SO LIST WILL BE ALL RIGHT
I will just stick to IPO Since chittorgarh.com is against secondary market tips
did little bit of tweaking brought three small and mid cap pharma stock one IT distribution company again small cap and watch dial company would like to share however Chittorgarh has advice not to use
Attention: Pls do not use IPO Grey Market Forum to discuss secondary market. however they have suggested to use Stock message board however i find the board full of paid stooge recommending operators calls so do not see any purpose in posting in that message board
Please do post your opinion about Market or any other secondary market stock. We always appreciated your views and recommendations. Please ignore if someone not like the same as i think most of members wants to hear from you...
As such there is no company in India whose business portfolio is comparable with that of GSBPL business to be compared as a peer group companies, although Serum Institute India Limited is a company which is acting in the same field as GSBPL is. However it is an a unlisted company.
Paid up share capital has increased from Rs 15.34 cr as on 31.03.2016 to Rs 38.36 cr as on 30.06.2016. Reserves have been reduced to that extent. Issue of Bonus shares?
At rs.80 per share the market cap of this would be 305 crore. As per last year''s profit P/E comes around 57. While extrapolating current years earning it comes around 27. As per valuation Looks a good bet. Correct me if I m wrong with above numbers
this company got 500 crore supply order for 2016-17 and 2017-8 from Ministry of health and family welfare GOI at Rs 32/vaccine in 2016-17 and Rs 37 for 2017-18.